ENGLISH ABSTRACT
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Erysipelas--course of disease, recurrence, complications; a 10 years retrospective study].

OBJECT: we studied erysipelas by conducting a retrospective analysis of 319 patients with erysipelas treated in Dermatology Department Jagiellonian University in Krakow between 1994 and 2004.

METHODS: we performed a retrospective analysis of 319 patients hospitalized for erysipelas in our institution during a 10 year period. The statistical significance was examined by chi square and Kruskal-Wallis test (significant value p< or =0.05).

RESULTS: there were 35% males and 65% females patients. Median age was 63 years. Most of the female patients were pensioners (32.7%), most of the male patients were physical workers (40.5%). Summer time was the most frequent season for hospitalization (32.3%), and winter time was the rarest (17%). Most of the erysipelas has involved the lower limb (59.2%). There was significant dependence between the regional risk factors and occupation. The recurrent cases occurred in 67.3% cases with lower limb localisation in 69.44% cases. The most rare recurrent cases found on upper limb (6%). The systemic risk factors were associated with recurrent erysipelas in 69.44%. Complications, such as abscess formation, lymphangitis, venous insufficiency, osteitis, arthritis, septic tendonitis and elephantiasis were found in 25%.

CONCLUSIONS: after review of the literature and our experiences it is clear that there is a strong need for interdisciplinary treatment to avoid various potential complications of erysipelas.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app